In caring for patients with primary gliomas or metastatic brain tumors, there are few absolute standards of care and much controversy over which approaches are best. Is there just one optimal treatment modality for a particular patient? Are several different approaches reasonable? Are there novel solutions that merit further exploration? Our prestigious panel of experts in neuro-oncology, radiation oncology, and neurosurgery discuss the benefits and limitations of recent biological and clinical advances.